Fundly.ai Raises $4M Seed Round Led by Multiply Ventures

Fundly.ai Secures $4M Seed Round

Fundly.ai, a pharma supply chain startup, has raised $4 million in seed funding. The round was led by Multiply Ventures, with participation from Accel and Rajeev Ahuja. The funding was announced on September 7, 2026.

What Fundly.ai Does

Fundly.ai operates in the pharmaceutical supply chain space, serving retailers and distributors. The company provides financial solutions that equip these businesses to manage better cash flows and increase margins. By addressing the financial needs of pharma retailers and distributors, Fundly.ai aims to strengthen the overall supply chain.

Funding Details

• Round Type: Seed
• Amount Raised: $4,000,000 USD
• Lead Investor: Multiply Ventures
• Additional Investors: Accel, Rajeev Ahuja
• Funding Date: September 7, 2026

Investor Perspective

The participation of Multiply Ventures as lead investor, along with Accel and Rajeev Ahuja, signals confidence in Fundly.ai's approach to solving financial challenges within the pharma supply chain. This seed funding will likely support the company's growth and expansion efforts.

About Fundly.ai

Fundly.ai is a pharma supply chain startup that services retailers and distributors. Its focus is on financially equipping these stakeholders to manage better cash flows and increase margins. The company is based at fundly.ai.

Implications for the Pharma Supply Chain

The pharma supply chain is complex, with retailers and distributors often facing cash flow challenges that can impact their operations and profitability. Fundly.ai's solutions aim to address these issues directly, potentially leading to more efficient and financially stable supply chain participants. This funding round will enable Fundly.ai to further develop and scale its offerings.

Conclusion

With $4 million in fresh capital, Fundly.ai is positioned to advance its mission of improving financial management for pharma retailers and distributors. The backing from experienced investors underscores the potential of its approach in a critical industry.